Cite
Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE.
MLA
Hui Wang, et al. “Assessment of the Pre-Clinical Immunogenicity of a New VEGF Receptor Fc-Fusion Protein FP3 with ELISA and BIACORE.” Cancer Immunology, Immunotherapy, vol. 59, no. 2, Feb. 2010, pp. 239–46. EBSCOhost, https://doi.org/10.1007/s00262-009-0744-1.
APA
Hui Wang, Jing Shi, Qin Wang, Hong Li, Kun Cai, Xiaojun Hou, Tao Li, Qi Zhong, & Dechao Yu. (2010). Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE. Cancer Immunology, Immunotherapy, 59(2), 239–246. https://doi.org/10.1007/s00262-009-0744-1
Chicago
Hui Wang, Jing Shi, Qin Wang, Hong Li, Kun Cai, Xiaojun Hou, Tao Li, Qi Zhong, and Dechao Yu. 2010. “Assessment of the Pre-Clinical Immunogenicity of a New VEGF Receptor Fc-Fusion Protein FP3 with ELISA and BIACORE.” Cancer Immunology, Immunotherapy 59 (2): 239–46. doi:10.1007/s00262-009-0744-1.